Completed PHASE1 INTERVENTIONAL 3-arm
NCT07001501
A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Itraconazole Capsules (ICZ)
Sponsor: Henan Genuine Biotech Co., Ltd.
Conditions
Healthy
Interventions
Azvudine tablets(FNC) and Itraconazole Capsules (ICZ)
Updated 1 time since 2025 Last updated: May 23, 2025 Started: Feb 21, 2022 Primary completion: Apr 25, 2022 Completion: Mar 13, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07001501, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by Henan Genuine Biotech Co., Ltd., it has been updated 1 time since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Henan Genuine Biotech Co., Ltd.
Data source: Henan Genuine Biotech Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .